GRIFOLS, S.A.

GRF
Real-time Estimate Quote. Real-time Estimate  - 09/28 03:59:53 pm
8.985EUR -6.29%

Turn to zoom
Prev.9.08200000
Open9.48000000
High9.62200000
Low9.04400000
Volume2 699 332
Latest news
7h ago
1d ago
2d ago
2d ago
Chart GRIFOLS, S.A.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance10,812,512,5
Spread/Res.-16%-27%-27%
Spread/Supp.0,08%17%12%
Support9,087,748,14
Financials
Sales 2022 5 783 M 5 576 M 5 576 M
Net income 2022 345 M 333 M 333 M
Net Debt 2022 8 749 M 8 437 M 8 437 M
P/E ratio 2022 16,4x
Yield 2022 0,51%
Capitalization 5 557 M 5 359 M 5 359 M
EV / Sales 2022 2,47x
EV / Sales 2023 2,12x
Nbr of Employees 27 584
Free-Float 79,8%
Company
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:
- products derived from plasma (77.3%):...
Sector :
Biopharmaceuticals
Calendar :
2023-03-02 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 9,08 €
Average target price 21,71 €
Spread / Average Target 139%